Skip to content
10-K

Annual Report

US-China Biomedical Technology, Inc.

0001683168-18-001683

← back to feed
Filed
Jun 13, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Jun 12, 2018 15.53M sh
Cash And Equivalents FY 2018 · Feb 28, 2018 $56.41K
Cash And Equivalents FY 2018 · Feb 28, 2017 $3.37K
Operating Cash Flow FY 2018 · Feb 28, 2017 −$63.81K
Total Liabilities FY 2018 · Feb 28, 2017 $14.15K
Current Assets FY 2018 · Feb 28, 2017 $6.04K
Total Assets FY 2018 · Feb 28, 2017 $6.04K
Sga Expense FY 2018 · Feb 28, 2017 $44K
Net Income FY 2018 · Feb 28, 2017 −$44.8K
Stockholders Equity FY 2018 · Feb 29, 2016 −$27.81K